Evidence map›Paper›PMID 24901344›Full record

ArticlePLoS pathogens2014

Dusp3 and Psme3 are associated with murine susceptibility to Staphylococcus aureus infection and human sepsis.

Qin Yan, Batu K Sharma-Kuinkel, Hitesh Deshmukh, Ephraim L Tsalik, Derek D Cyr, Joseph Lucas, Christopher W Woods, William K Scott, Gregory D Sempowski, Joshua T Thaden and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Dual-Specificity Phosphatases in Immunity and Infection: An Update.International journal of molecular sciences · 2019
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

  • Erratum issued
    Thaden, Joshua [corrected to Thaden, Joshua T]
5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Qin YanDivision of Infectious Diseases & International Health, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.
Batu K Sharma-KuinkelDivision of Infectious Diseases & International Health, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.
Hitesh DeshmukhDivision of Neonatology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Ephraim L TsalikDivision of Infectious Diseases & International Health, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America; Emergency Medicine Service, Durham Veteran's Affairs Medical Center, Durham, North Carolina, United States of America; Duke Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina, United States of America.
Derek D CyrDuke Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina, United States of America.
Joseph LucasQuintiles Innovations, Morrisville, North Carolina, United States of America.
Christopher W WoodsDivision of Infectious Diseases & International Health, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America; Duke Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina, United States of America; Section on Infectious Diseases, Durham Veteran's Affairs Medical Center, Durham, North Carolina, United States of America.
William K ScottHussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, United States of America; Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Gregory D SempowskiDuke Human Vaccine Institute, Durham, North Carolina, United States of America.
Joshua T Thaden
Joshua ThadenDivision of Infectious Diseases & International Health, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America; Duke Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina, United States of America; Duke Clinical Research Institute, Durham, North Carolina, United States of America.
Thomas H RudeDivision of Infectious Diseases & International Health, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.
Sun Hee AhnDepartment of Biochemistry School of Dentistry, Chonnam National University, Bukgu, Gwangju, Korea.
Vance G FowlerDivision of Infectious Diseases & International Health, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America; Duke Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina, United States of America; Duke Clinical Research Institute, Durham, North Carolina, United States of America.
Duke University · USClinical Research Institute · USChonnam National University · KRDurham VA Medical Center · USIQVIA (United States) · USUniversity of Miami · USUniversity of Pennsylvania · US

Funding

Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
Host Susceptibility to S. aureusR01AI068804 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G. · 2007 to 2016
$6.9M
Mentoring Patient Oriented Research in Antibiotic-Resistant BacteriaK24AI093969 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G. · 2011 to 2020
$1.6M
CSRD VA IK2 CX000530NIAID NIH HHS K24 AI093969NIAID NIH HHS R01 AI068804NIAID NIH HHS UC6 AI058607
6 · The paper itself

Abstract

Using A/J mice, which are susceptible to Staphylococcus aureus, we sought to identify genetic determinants of susceptibility to S. aureus, and evaluate their function with regard to S. aureus infection. One QTL region on chromosome 11 containing 422 genes was found to be significantly associated with susceptibility to S. aureus infection. Of these 422 genes, whole genome transcription profiling identified five genes (Dcaf7, Dusp3, Fam134c, Psme3, and Slc4a1) that were significantly differentially expressed in a) S. aureus -infected susceptible (A/J) vs. resistant (C57BL/6J) mice and b) humans with S. aureus blood stream infection vs. healthy subjects. Three of these genes (Dcaf7, Dusp3, and Psme3) were down-regulated in susceptible vs. resistant mice at both pre- and post-infection time points by qPCR. siRNA-mediated knockdown of Dusp3 and Psme3 induced significant increases of cytokine production in S. aureus-challenged RAW264.7 macrophages and bone marrow derived macrophages (BMDMs) through enhancing NF-κB signaling activity. Similar increases in cytokine production and NF-κB activity were also seen in BMDMs from CSS11 (C57BL/6J background with chromosome 11 from A/J), but not C57BL/6J. These findings suggest that Dusp3 and Psme3 contribute to S. aureus infection susceptibility in A/J mice and play a role in human S. aureus infection.

Indexed as

Disease SusceptibilityGene Expression RegulationAnimalsAnimals, Genetically ModifiedAutoantigensBacteremiaCell Line, TransformedCells, CulturedDual Specificity Phosphatase 3FemaleGenome-Wide Association StudyHumansImmunity, InnateMacrophagesMaleMiceAutoantigensDual Specificity Phosphatase 3DUSP3 protein, humanDusp3 protein, mouseKi antigenProteasome Endopeptidase ComplexRecombinant Proteins

Identifiers

PMID24901344
PMCPMC4047107
OpenAlexW2078664899

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.